Ledger.Open graph →
SEC Form D · filed March 19, 2024

Lindy Biosciences, Inc

Offering
$2.5M
Sold
$1.7M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
Morrisville, NC
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (8)

Karen Levert · Durham, NCDirectorOmar Flores · Research Triangle Park, NCExec · DirectorDeborah Bitterfield · Durham, NCExec · Director · PromoterJoel Whitley · Houston, TXDirectorKaren Levert · Durham, NCDirectorOmar Flores · Research Triangle Park, NCExec · DirectorDeborah Bitterfield · Durham, NCExec · Director · PromoterJoel Whitley · Houston, TXDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗